Podcasts about screenings

Jana bespricht die Hygiene-Implikationen von Nail-Design, Hannes schaut , ob sich zu seinen Beiträgen des letzten Jahres was Neues ergeben hat, Ilj a hat das Deutsche Ärzteblatt, das NEJM und die Zuhörer:innen-Fragen verarbeitet.

Program notes:0:40 Screening young adults for CRC1:40 Four different screening options2:41 Awareness issue3:40 "Yuck" factor associated4:34 Persistent Covid infections and variants5:35 Who ends up with variants?6:35 Did not render more infectious7:35 Humans as mixing vessels7:50 How do men and women respond to antithrombotics8:50 15% reduction in MI9:58 Long term contraceptives free and uptake10:58 48% of pregnancies in North America unintended11:58 Increase in any type of contraception12:38 Cost is an important contributor13:24 End

00:00 Introduction to Hypertension 00:38 Welcome to Cardio Buzz 01:01 Understanding Primary Aldosteronism 02:27 Health Risks of Primary Aldosteronism 02:59 Screening for Primary Aldosteronism 05:00 Diagnosis and Interpretation 09:46 Adrenal Vein Sampling 14:22 Surgical and Medical Treatments 19:50 Conclusion and Final Thoughts

In this episode, host Steven Newmark breaks down four critical public health stories making headlines: Senators Angus King and Elizabeth Warren introduce a resolution to defend the U.S. Preventive Services Task Force amid reports that RFK Jr. may fire its members. What’s really at stake if the Task Force is dismantled—and how evidence-based guidelines are already saving lives, from colon cancer screenings to heart health. A deadly outbreak of Legionnaires’ disease in Harlem has claimed two lives and sickened dozens. What you need to know if you live in the area. The alarming defunding of mRNA vaccine research. Science, policy, and prevention—all in one sharp, timely episode. Contact Our Host Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org A podcast episode produced by Ben Blanc, Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Listen to all episodes of The Health Advocates on our website (https://ghlf.org/the-health-advocates) or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

INTERVIEW: Director Margaret Gordon on new film 'Life In One Chord' screening at NZIFF 2025 by Zac Hoffman on Radio One 91FM Dunedin

Jerry opens the show by talking about CSIS security screenings, and how immigration lawyers say it is causing delays in processing newcomers to Canada. Urban affairs reporter, John Lorinc, speaks with Jerry about the feasibility of a tunnel under the 401, and the latest possible delay in the Eglinton Crosstown LRT. Minister Nolan Quinn discuss Ontario's Investment of $56.8 million to expand nursing enrollment. Jesse Rogerson weighs in on NASA wanting the US to be the first nation to put a nuclear reactor on the moon.

Sara Gray, Illinois Executive Director of the National Alliance on Mental Illness, joins Megan Lynch. A bill recently signed into law by Illinois Governor JB Pritzker requires all public school districts to offer mental health screenings to students enrolled in grades 3 through 12, at least once a year, beginning with the 2027-2028 school year.

Unsere Kinotipps im August: - Die guten und die besseren Tage - Mit dem Feuer spielen - Caught Stealing - Wenn der Herbst naht

We're diving into the first-ever treatment that can delay the onset of type 1 diabetes—Tzield—and hearing from two powerful voices helping spread the word about screening. First, Pelaton star Robin Arzon shares her personal journey - managing diabetes through marathons, pregnancy, and parenting—and why she believes time and information are two of the most valuable tools in diabetes care. We're also going to learn more about Tzield itself from Dalila Masic, PharmD. We're talking about how this works now, who its for, and the future of prevention. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about Tzield here Robin Arzon and Barbie video here  Join us at an upcoming Moms' Night Out event! Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

What if you could learn about type 1 diabetes before symptoms even appear? In this powerful episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with Senior Football Insider and Sanofi Spokesperson Adam Schefter to talk about why early screening for T1D is a conversation every family should be having.Adam shares his personal connection to type 1 diabetes through his wife's experience and how it changed his outlook on health, preparation, and the role of care partners. Together, they break down the importance of understanding early-stage T1D, how screening works, and why early knowledge is more than just information—it's peace of mind.Whether you're newly diagnosed, a care partner, or simply looking to stay informed, this episode offers insight, support, and a meaningful call to action.Key Topics:Adam's connection to T1D: How his wife's diagnosis impacted their family and sparked his passion for awareness and advocacy.Why early screening matters: The power of knowing about type 1 diabetes before symptoms begin—and how it can change everything.Understanding early-stage T1D: What auto antibodies are, what they indicate, and how type 1 develops in stages.Advice for care partners and families: Why loved ones should consider screening too, and how to start the conversation with a healthcare provider.Awareness is everything: How misinformation and lack of understanding can delay diagnosis—and why it's time to change that.Start the conversation: How to learn more about screening and what families can do today to stay one step ahead. ★ Support this podcast ★

A new blood test for colorectal cancer finds advanced cancers well, but William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says when compared to the gold standard colonoscopy, or even stool tests used for screening, it falls … Are there aspects to blood testing for colorectal cancer that undermine screening? Elizabeth Tracey reports Read More »

A new blood test used to screen people for colorectal cancer just isn't ready to replace colonoscopy or fecal immunochemical tests, since these are capable of detecting early lesions that respond best to treatment. That's according to Kimmel Cancer Center … Could more targeted screening be helpful in colorectal cancer? Elizabeth Tracey reports Read More »

Learn more at TheCityLife.org

Peter McDowell joins Rick Kogan to talk about his film, ‘Jimmy in Saigon’. Peter dives in on the true meaning of the film and his family’s reaction to the idea of making a film about his late brother. Screening for the film is Friday, August 22nd at 7pm and Sunday, August 24th at 6pm at […]

“Colorectal cancer treatment is not just about eliminating a disease. It's about preserving life quality and empowering patients through every phase. So I think nurses are really at the forefront that we can do that in the oncology nursing space. So from early detection to survivorship, the journey is deeply personal. Precision medicine, compassionate care, and informed decision-making are reshaping outcomes. Treatment's just not about protocols. It's about people,” ONS member Kris Mathey, DNP, APRN-CNP, AOCNP®, gastrointestinal medical oncology nurse practitioner at The James Cancer Hospital of The Ohio State University Wexner Medical Center in Columbus, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about colorectal cancer treatment.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 1.0 contact hour of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 1, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the treatment of colorectal cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 370: Colorectal Cancer Screening, Early Detection, and Disparities Episode 153: Metastatic Colorectal Cancer Has More Treatment Options Than Ever Before ONS Voice articles: Colorectal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) How Liquid Biopsies Are Used in Cancer Treatment Selection Oncology Drug Reference Sheet: 5-Fluorouracil Oncology Drug Reference Sheet: Oxaliplatin What Is a Liquid Biopsy? Clinical Journal of Oncology Nursing article: Colorectal Cancer in Young Adults: Considerations for Oncology Nurses Oncology Nursing Forum article: Neurotoxic Side Effects Early in the Oxaliplatin Treatment Period in Patients With Colorectal Cancer ONS Colorectal Cancer Learning Library ONS Biomarker Database (filtered by colorectal cancer) ONS Peripheral Neuropathy Symptom Interventions American Cancer Society colorectal cancer resources CancerCare Colorectal Cancer Alliance Colorectal Cancer Resource and Action Network Fight Colorectal Cancer National Comprehensive Cancer Network To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Colorectal cancer has several different types, but there is one that dominates the landscape, and that is adenocarcinoma. So I think most of us have heard that. It's fairly common, and it accounts for about 95% of all colorectal cancers. It begins in the glandular cells lining the colon or rectum and often develops from polyps, in particular adenomatous polyps.” TS 1:41 “One of the biomarkers that we'll most commonly hear about is KRAS or NRAS mutations. This indicates tumor genetics, and these mutations suggest resistance to our EGFR inhibitors such as cetuximab. BRAF mutation or V600E is a more aggressive tumor subtype, and those may respond to our BRAF targeted therapy. … And then our MSI-high or MMR-deficient—microsatellite instability or mismatch repair deficiency—that really predicts an immunotherapy response and may indicate Lynch syndrome, which is a huge genetic component that takes a whole other level of counseling and genetic testing with our patients as well.” TS 6:02 “Polypectomy or a local excision—that removes our small tumors or polyps during that colonoscopy. And that's what's used for those stage 0 or early stage I cancers. A colectomy removes part or all of the colon. This may be open or laparoscopic. It can include a hemicolectomy, a segmental resection, or a total colectomy, so where you take out the entire part of the colon. A proctectomy removes part or all of the rectum. This may include a low anterior resection, also known as an LAR … or an abdominal perineal resection, which is an APR. … Colostomy or ileostomy—that diverts the stool to an external bag via stoma. Sometimes this is temporary or permanent depending on the type of surgery.” TS 14:11 “We'll have our patients say, ‘Hey, I want immunotherapy therapy. I see commercials on it that it works so well.' We have to make sure that these patients are good candidates for it, also that we're treating them adequately. We need to make sure that they have those biomarkers, so as I mentioned, the MSI-high or MMR tumors. Our MSS-stable tumors—they may benefit from newer combinations or clinical trials. Metastatic disease—immunotherapy may be used alone or with other treatments. And then in the neoadjuvant setting, some trials are really showing promising results using immunotherapy prior to surgery.” TS 25:38 “Antibody-drug conjugates are really an exciting frontier in all cancer treatments as well as colorectal cancer treatment. This is used mainly for patients with advanced or treatment-resistant disease, and these therapies combine the targeted power of monoclonal antibodies with the cell-killing ability of potent chemotherapy agents. They're still on the horizon for the most part in colorectal cancer. However, there is only one approved antibody-drug conjugate, or ADC, at this time, and that's trastuzumab deruxtecan, or Enhertu. That's approved for any solid tumor, such as colorectal cancer with HER2 IHC 3+. So again, looking back at that pathology in those markers, making sure that you have that HER2 mutation and that IHC.” TS 35:00 “There are a few myths going around about colorectal cancer treatment that can lead to confusion or even delayed care. One myth is only older men get colorectal cancer. As you heard me talk in my previous podcast on screening, unfortunately, this isn't necessarily true. Colorectal cancer affects both men and women and our cases in the younger population are rising. So our screening guidelines have changed to age 45 because we are seeing it in the younger population.” TS 45:54

This week, Brent Leuthold joins me to review the new MCU movie, The Fantastic Four: First Steps in a feature review and then, in this week's secondary review, I talk about the Alison Brie/Dave Franco horror movie Together. We also discuss recent movie and TV news, screenings around Indianapolis, and more.   Timestamps Show Start - 00:28 Introducing Brent - 02:11 Screening in Indy - 11:43 News Before the Reviews - 13:56 Feature Review The Fantastic Four: First Steps (2025) - 32:13 Spoiler - 59:16 Secondary Review Together (2025) - 1:23:51 Spoiler - 1:40:16   Closing the Ep - 1:46:31 Patreon Clip - 1:47:33   Related Links As Good As It Gets new album COLORS on 12" VINYL RELEASE Amazon's Alexa Fund Invests in ‘Netflix of AI' Start-Up Fable, Which Launches Showrunner: A Tool for User-Directed TV Shows ‘Mrs. Doubtfire' Star Matthew Lawrence Wants AI To Revive Robin Williams' “Iconic” Voice DreamWorks Includes AI Training Warning In The Bad Guys 2 End Credits Alison Brie and Dave Franco Face Copyright Suit Over $17 Million Sundance Hit ‘Together': ‘A Blatant Rip-Off' Dave Franco and Alison Brie's ‘Together' Director Responds to Idea Theft Lawsuit and Calls It ‘Deeply Unsettling'   Brent's Letterboxd Awake in the Dark Brent's Review of The Fantastic Four: First Steps Brent's Essay on Wild at Heart for Midwest Film Journal's Willem Dafoe Series Brent's Review of Eddington   My 2025 Podcast and Writing Archive Immediate Reaction - Together (2025) - Jul 23, 2025 Patreon Special - 28 Days Later (2002) at Alamo Drafthouse - May 23, 2025 Patreon Companion Episodes Collection Patreon - Severance Episode Reviews Indianapolis Theaters Alamo Drafthouse Indy Kan-Kan  Living Room Theaters Keystone Art  Flix Brewhouse Ways to Support Us Support Us on Patreon for Exclusive Content Official OV Merch Buy Me A Coffee Obsessive Viewer Obsessive Viewer Presents: Anthology Obsessive Viewer Presents: Tower Junkies As Good As It Gets - Linktree Start Your Podcast with Libsyn Using Promo Code OBSESS Follow Us on Social Media My Letterboxd | YouTube | Facebook | Twitter Instagram | Threads | Bluesky | TikTok | Tiny's Letterboxd Mic Info Matt: ElectroVoice RE20 into RØDEcaster Pro II (Firmware: 1.6.5) Brent: Earthworks ICON Pro in Google Meet   Episode Homepage: ObsessiveViewer.com/OV485   Next Week on the Podcast OV486 - The Naked Gun (2025) & TBD (2025)

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAFP/NCPD/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PEW865. CME/AAFP/NCPD/CPE/IPCE credit will be available until July 23, 2026.A Light on the Horizon: Improving Alzheimer's Screening and Diagnosis Through Quality Improvement In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and PeerView Institute. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAFP/NCPD/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PEW865. CME/AAFP/NCPD/CPE/IPCE credit will be available until July 23, 2026.A Light on the Horizon: Improving Alzheimer's Screening and Diagnosis Through Quality Improvement In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and PeerView Institute. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAFP/NCPD/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PEW865. CME/AAFP/NCPD/CPE/IPCE credit will be available until July 23, 2026.A Light on the Horizon: Improving Alzheimer's Screening and Diagnosis Through Quality Improvement In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and PeerView Institute. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAFP/NCPD/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PEW865. CME/AAFP/NCPD/CPE/IPCE credit will be available until July 23, 2026.A Light on the Horizon: Improving Alzheimer's Screening and Diagnosis Through Quality Improvement In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and PeerView Institute. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAFP/NCPD/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PEW865. CME/AAFP/NCPD/CPE/IPCE credit will be available until July 23, 2026.A Light on the Horizon: Improving Alzheimer's Screening and Diagnosis Through Quality Improvement In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and PeerView Institute. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAFP/NCPD/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PEW865. CME/AAFP/NCPD/CPE/IPCE credit will be available until July 23, 2026.A Light on the Horizon: Improving Alzheimer's Screening and Diagnosis Through Quality Improvement In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and PeerView Institute. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAFP/NCPD/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PEW865. CME/AAFP/NCPD/CPE/IPCE credit will be available until July 23, 2026.A Light on the Horizon: Improving Alzheimer's Screening and Diagnosis Through Quality Improvement In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and PeerView Institute. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAFP/NCPD/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PEW865. CME/AAFP/NCPD/CPE/IPCE credit will be available until July 23, 2026.A Light on the Horizon: Improving Alzheimer's Screening and Diagnosis Through Quality Improvement In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and PeerView Institute. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

Story at-a-glance Most people with liver damage have no symptoms and receive a diagnosis only after irreversible scarring has occurred, making early detection and lifestyle changes essential Standard blood tests often miss early-stage liver fibrosis, even when enzyme levels are "normal," delaying diagnosis until complications like cirrhosis or liver cancer appear The real threat isn't liver fat, but fibrosis — scar tissue that silently builds up from insulin resistance, inflammation, toxic fats like vegetable oils and alcohol Choline is a key nutrient that helps your liver move fat out before it causes damage; pastured egg yolks are the best source, but many people don't get enough from food alone Removing vegetable oils and alcohol, eating choline-rich foods, trimming belly fat, and moving daily help reduce liver stress and reverse fibrosis before it's too late

Kate, Mark, Gary and Henry discuss 4 important new studies relevant to primary care clinicians: negative pressure wound therapy for wounds healing by secondary intention, comparative effectiveness of acute migraine treatments, contrast enhanced mammography, US, or MRI for women with dense breasts, and metformin for knee pain in patients without diabetes.Negative pressure wound therapy: https://pubmed.ncbi.nlm.nih.gov/40250455/ Acute migraine treatments: https://pubmed.ncbi.nlm.nih.gov/40096693/ Best enhanced screening for women with dense breasts:  https://pubmed.ncbi.nlm.nih.gov/40412427/ Metformin for knee pain in patients without DM: https://pubmed.ncbi.nlm.nih.gov/40274279/

New state law will expand mental health screenings for students beginning in the 2027-2028 school year

New state law will expand mental health screenings for students beginning in the 2027-2028 school year

New state law will expand mental health screenings for students beginning in the 2027-2028 school year

Aviation Week Network editors discuss whether it's the right time to update airport security rules and restrictions that have been in place since the Sept. 11, 2001, terrorist attacks.

Youth FX's Solidarity Screening Series presents Speed Girls on Friday August 1. The movie tells the story of an all woman street race team in the West Bank, Palestine. Moses Nagel spoke with Hana Maaiah of the Palestinian Rights Committee who is co-sponsoring the event.

Hosts LeAlec Murray, Haley Whisennand, and Alex Lebl have a LOT to say after SDCC 2025, and we're breaking down Demon Slayer's recording-breaking opening weekend in Japan, the anime winners at the 2025 Collision Awards, Crunchyroll's Anime NYC schedule, the anime titles coming to theaters for Anime Nights this fall, and more. THEN, hosts debate whether the Naruto or One Piece universe would win in a fight and share your anime vehicles of choice. Have a question for The Anime Effect? Ask it here. To bring your brand to life in this podcast, email podcastadsales@sonymusic.com. Japan Box Office: Demon Slayer: Kimetsu no Yaiba Infinity Castle First Movie Opens at No.1 Demon Slayer: Kimetsu no Yaiba Collabs with Los Angeles Dodgers on August 15 Game Demon Slayer: Kimetsu no Yaiba Infinity Castle First Movie Releases New Visual Featuring Tanjiro and Giyu Versus Akaza Solo Leveling Season 2, HAIKYU!! The Dumpster Battle and More Anime Recognized at 2025 Collision Awards Crunchyroll Heads to Anime NYC with Special Panels, Screenings and More Crunchyroll Anime Nights Movie Program Launches in the U.S. with Miss Kobayashi's Dragon Maid, OVERLORD Screenings Mamoru Hosoda's The Boy and the Beast Re-Releases in U.S. Theaters in August EXCLUSIVE: Oldboy Manga Deluxe Edition Debuts in January 2026 Junji Ito Enters Eisner Awards Hall of Fame Learn more about your ad choices. Visit podcastchoices.com/adchoices

On the forty- seventh episode of All the Film Things, I had the pleasure of interviewing educator Art Smith jr.! Art Smith jr. has been working in the industry for over 50 years and has mentored over 400 individuals and counting. He has worked behind the camera in various roles such as a production assistant, project manager, and prop master for well- known feature films such The Way We Were, Good Morning, Vietnam, and The Bucket List and also under the direction of acclaimed filmmakers including Brian de Palma, and Martin Scorsese. Art is a member of several prestigious organizations in the industry including the American Film Institute and the Academy of Motion Picture Arts and Sciences TV. He is also the owner of the production company No Budget Movie Company and is a producing partner of Code7 Films. Art has worked in several different mediums including film, television, and music videos, one of which, for the song “Talking to the Wall”, earned him both a Telly Award and Aurora Award in 1999. Just last month, Art was awarded the Lifetime Achievement Award at the Orlando International Film Festival. Aside from his work on set, Art is a proud retired veteran who served in the US Army for 30 years. Art has been the Principal Secretary and on the Board of Directors of the Florida chapter of the non- profit organization Women in Film and Television (WIFT) for nearly twenty years and three exciting new programs, the Veterans program, Handicapped program, and Screening program, were recently launched. Go to WomeninFilmFL.org to learn more about the organization as well as grants, programs, and upcoming events. And if you're not in Florida, go to https://www.wifti.net to find your local WIFT chapter!This is Art's first time on ATFT! I've known Art for nearly three years now through attending WIFT events. At the first event I met him at, he stayed back for a few hours to chat with students answering their questions. Not long after meeting him, we had a phone call that lasted over three hours. I always look forward to seeing and talking with him at WIFT events because I always learn so much and have greatly benefited from his advice. Last spring, I asked Art if he'd be interested in coming on ATFT and he said yes instantly. Even so, this episode came together quickly but I was thrilled to finally have him on!  This episode was originally 2 hours and 22 minutes so I unfortunately had to trim it down. I apologize if the audio quality is not like previous episodes, it was a challenging edit to complete in less than two weeks. This episode was recorded on July 9, 2025. In this episode, Art tells unbelievable star- studded stories from his career, from Sean Connery tracking him down to what happened when Jack Nicholson heard Art's impression of him to his friendship James Brolin, as well as the incredible opportunities Art gave his TV production students through the years. Art also talks about the business behind filmmaking at length including deals that fell through and guiding young filmmakers to success. All this and much more on the latest episode of All the Film Things!Background music created and used with permission by the Copyright Free Music - Background Music for Videos channel on YouTube.

This week on Militantly Mixed, host Sharmane Fury is joined by filmmaker Sarah Shuman, who is not only a brilliant creative mind but also a member of the planning committee for Free To Be Fest. In this episode, Sarah shares her powerful experience screening her film, TSEHAI, at last year's Free To Be Fest—for the first time ever with a fully Mixed audience.We dig into what it means to be seen, heard, and understood through the lens of a shared cultural identity—and how transformative that is compared to screening in predominantly non-Mixed spaces on the broader film festival circuit.Watch Sarah's short film “TSEHAI” here:⁠https://youtu.be/VhGhFGHHnjw?si=uGouMoOyKeCd7xZZ⁠Visit Sarah's sustainable picnic company, Solstice Picnics here.https://solsticepicnics.com/ or IG: https://www.instagram.com/solsticepicnics?igsh=NTc4MTIwNjQ2YQ%3D%3D&utm_source=qrAt the time of airing, we are just 11 days away from the Free To Be Fest, happening August 9, 2025, in Los Angeles!Get your tickets now: https://freetobefest2025.rsvpify.com/Support our mission by donating or sponsoring someone else's attendance: https://www.paypal.com/biz/profile/freetobefestWhether you're Mixed, allied, or just curious, this episode is a beautiful reminder of why representation and safe spaces by and for us matter.Militantly Mixed is a ManeHustle Media podcast, hosted and produced by Sharmane Fury.Support the show on Patreon: https://www.patreon.com/sharmanefury

There has been a marked increase in bowel cancers amongst younger people in Australia, and scientists and doctors are researching to find out what is going on.  

Cozy Earth: Go to https://cozyearth.com and use code ICH for 40% off the softest bedding, bath and apparel! Pipedrive: Try it free for 30 days at https://pipedrive.com/iced Range Rover Sport: Start designing your Range Rover Sport today at https://www.rangerover.com/us/sport Shopify: Sign up for a $1 per month trial period at https://shopify.com/ich MagicMind: Get 60% off the Magic Mind offer here: https://magicmind.com/ich #magicmind #mentalwealth #mentalperformancecoach Follow Dave Asprey: On Youtube - https://www.youtube.com/c/daveaspreybpr On Instagram - https://www.instagram.com/dave.asprey/ On X - https://x.com/bulletproofexec Website - https://daveasprey.com/ Apply for The Index Membership: https://entertheindex.com/ Add us on Instagram: https://www.instagram.com/jlsselby https://www.instagram.com/gpstephan Official Clips Channel: https://www.youtube.com/channel/UCeBQ24VfikOriqSdKtomh0w For sponsorships or business inquiries reach out to: tmatsradio@gmail.com For Podcast Inquiries, please DM @icedcoffeehour on Instagram! Timestamps: 00:00:00 - Intro 00:01:30 - Departure from Bulletproof 00:04:13 - 4 types of “qualified” people 00:06:25 - Screening execs psychologically 00:12:02 - Firing People 00:14:04 - Ideal interview questions 00:16:28 - Sponsor - Cozy Earth 00:21:37 - What is “Type 1 or 2” 00:26:36 - Can mental training fix most issues? 00:32:51 - Medicine that reduce reaction time 00:35:31 - Are you happier than most people? 00:36:12 - How long can you live? 00:37:15 - Sponsor - Pipedrive 00:38:54 - Healthier at 180 than now 00:41:12 - How much have you spent on your body? 00:44:08 - Forgetfulness cured 00:50:33 - His early 20s 00:51:24 - Overcoming Asperger's 00:53:20 - Smart kids with Asperger's 00:54:49 - Making $6M and losing it by 26 00:57:47 - Beginning of your healing journey 01:00:26 - Limitless vs. Modafinil 01:05:19 - Craziest biohack you've tried 01:06:34 - Sponsor - Range Rover 01:07:32 - Sponsor - Shopify 01:09:01 - Stem cell treatments 01:12:24 - Most overprescribed medicine 01:13:17 - Rate these biohacks 01:18:47 - Practical biohack tips 01:22:00 - How to get perfect sleep 01:28:49 - Worst foods most people eat 01:29:59 - Best everyday food 01:33:30 - Dangerous biohacking experiences 01:34:18 - Anti-aging products 01:37:43 - Is tap water safe? 01:39:59 - Thoughts on Bryan Johnson 01:40:41 - Eating while traveling 01:41:28 - How bad is alcohol? 01:45:13 - Fried food and brain health 01:47:29 - Nicotine 01:51:13 - Adderall 01:59:11 - Dopamine detox 02:01:51 - Freezing yourself post mortem 02:05:37 - A question you wish people asked 02:07:11 - Why are you controversial? 02:10:43 - Best health tip to apply now *Some of the links and other products that appear on this video are from companies which Graham Stephan will earn an affiliate commission or referral bonus. Graham Stephan is part of an affiliate network and receives compensation for sending traffic to partner sites. The content in this video is accurate as of the posting date. Some of the offers mentioned may no longer be available. Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week, Sam Watermeier joins me to review the new slasher legacy sequel/reboot, I Know What You Did Last Summer in a feature review and then, in this week's secondary review, I talk about the new dark comedy Oh, Hi! We also discuss recent movie and TV news, screenings around Indianapolis, and more. Timestamps Show Start - 00:28 Introducing Sam - 02:35 Screening in Indy - 13:51 News Before the Reviews - 20:00 Feature Review I Know What You Did Last Summer (2025) - 39:42 Spoiler - 1:16:02 Exit Sam - 1:42:18 Secondary Review Oh, Hi! (2025) - 1:43:44 Closing the Ep - 2:01:46 Patreon Clip - 2:03:25 Related Links As Good As It Gets new album COLORS on 12" VINYL RELEASE Patreon Potpourri - 010 - "Scream Imitators" - I Know What You Did Last Summer (1997), I Still Know What You Did Last Summer (1998), Urban Legend (1998), and Valentine (2001) - Feb 4, 2022 The Late Show with Stephen Colbert to End in May 2026, Citing Financial Reasons  New ‘Wonder Woman' Movie Sets ‘Supergirl' Writer Ana Nogueira to Pen Script I Know What You Did Last Summer star makes huge horror blunder in saying the original movie walked so Wes Craven's Scream could run Malcolm-Jamal Warner Drowns: ‘The Cosby Show' & ‘The Resident' Actor Was 54 Ozzy Osbourne Dies: Black Sabbath Frontman, Solo Singer & Reality TV Star Was 76  Hulk Hogan Dies: Pro Wrestling Icon & Actor Was 71 Sam's Letterboxd Sam's Writing on Midwest Film Journal Sam's Review of I Know What You Did Last Summer (2025) Sam's Review of Sovereign Sam's Review of M3GAN 2.0 Sam's Review of 28 Years Later Sam's Appearance on Odd Trilogies Podcast ep 102: The Schwarzenegger-Reitman Comedies  Midwest Film Journal's Dafoe? Dafriend Essay Series My 2025 Podcast and Writing Archive Immediate Reaction - The Life of Chuck (2025) - May 29, 2025 Immediate Reaction - Together (2025) - Jul 23, 2025 Patreon Companion Episodes Collection Companion Ep - OV477 - Final Destination 1-5 Retrospective - May 24-25, 2025 Patreon - Severance Episode Reviews Indianapolis Theaters Alamo Drafthouse Indy Kan-Kan  Living Room Theaters Keystone Art  Flix Brewhouse Ways to Support Us Support Us on Patreon for Exclusive Content Official OV Merch Buy Me A Coffee Obsessive Viewer Obsessive Viewer Presents: Anthology Obsessive Viewer Presents: Tower Junkies As Good As It Gets - Linktree Start Your Podcast with Libsyn Using Promo Code OBSESS Follow Us on Social Media My Letterboxd | YouTube | Facebook | Twitter Instagram | Threads | Bluesky | TikTok | Tiny's Letterboxd Mic Info Matt: ElectroVoice RE20 into RØDEcaster Pro II (Firmware: 1.5.4) Sam: Samson Q2U via USB in Google Meet Episode Homepage: ObsessiveViewer.com/OV484   Next Week on the Podcast OV485 - The Fantastic Four: First Steps (2025) & Together (2025)

Let's hang out together and watch a movie.We're co-hosting a screening of THE THING at the FILM CENTER EAST with the Philadelphia Film Society. Buy your tickets and experience the magic of friendship, that dog, and Proto dressed as Benjamin Franklin. Let us know you want to party with us!Support the 70mm Patreon to join our VHS Village Discord and access exclusive episodes in the 70mm Vault like the 1990s Batman movies, Harry Potter, The Matrix, SHIN Godzilla, and over 70 others. Signing up for the Patreon also get your own membership card, member-only discounts on merch, and the ability to vote on future episodes!Don't forget you can visit our website to shop our storefront to buy prints and merch, follow us on Letterboxd, email the show, and much more.70mm is a ⁠TAPEDECK⁠ podcast, along with our friends at ⁠BAT & SPIDER⁠,  ⁠The Letterboxd Show⁠, ⁠Escape Hatch⁠, ⁠Will Run For...⁠, ⁠Lost Light⁠, ⁠The Movie Mixtape⁠, and ⁠Twin Vipers⁠.(Gone but not forgotten; ⁠Cinenauts⁠ + ⁠FILM HAGS⁠.) ★ Support this podcast on Patreon ★

“Next-generation sequencing, or NGS, can be used to help us determine if the patient has specific biomarkers we can identify and use to target for treatment. Certain findings can tell us if a particular treatment might work for that patient, and we can see if there are any genetic variants we might have a biomarker targeted agent to use to treat them with,” ONS member Jackie Peterson, MSN, RN, OCN®, NE-BC, MBA, ambulatory nurse manager at the University of Chicago Medical Center in Illinois, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about prostate cancer and biomarker testing.  This podcast is sponsored by AstraZeneca and is not eligible for NCPD contact hours. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod    Licensed under Creative Commons by Attribution 3.0   Episode Notes This episode is not eligible for NCPD. ONS Podcast™ episodes: Episode 324: Pharmacology 101: LHRH Antagonists and Agonists Episode 321: Pharmacology 101: CYP17 Inhibitors Episode 180: Learn How Nurse Practitioners Use Biomarker Testing in Cancer Care ONS Voice articles: An Oncology Nurse's Guide to Cascade Testing Genetic Disorder Reference Sheet: BRCA1 and BRCA2 Hereditary Disorders Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Germline and Somatic Variants: What Is the Difference? Help Patients Understand Genomic Variants of Unknown Significance Prostate Cancer Clinical Trials Don't Reflect Racial Diversity—And It's Getting Worse Over Time Prostate Cancer Disparities Disappear With Equal Access to Care Prostate Cancer Prevention, Screening, Treatment, and Survivorship Recommendations The Case of the Genomics-Guided Care for Prostate Cancer ONS book: Understanding Genomic and Hereditary Cancer Risk: A Handbook for Oncology Nurses ONS course: Genomic Foundations for Precision Oncology Clinical Journal of Oncology Nursing articles: Metastatic Prostate Cancer: An Update on Treatments and a Review of Patient Symptom Management Prostate Cancer: How Nurse Practicioners Can Aid in Disease Diagnosis and Management Oncology Nursing Forum article: Identification of Symptom Profiles in Prostate Cancer Survivors Other ONS Resources: Biomarker Database (refine by prostate cancer or specific biomarkers) Clinical tool/case study: Biomarker Testing in Prostate Cancer: The Role of the Oncology Nurse Genomics and Precision Oncology Learning Library Huddle Card: Genomic Biomarkers Infographic: Talking to Your Patient About a Germline Variant of Uncertain Significance (VUS) American Cancer Society - Genetic Testing and Counseling for Prostate Cancer Risk American Cancer Society - Prostate Cancer Clinicaltrials.gov National Cancer Institute - Prostate Cancer National Comprehensive Cancer Network ZERO Prostate Cancer To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode “Some of the risk factors for developing prostate cancer include age, race, family history, and certain genetic changes or variants. Prostate cancer has some hereditary components, but most prostate cancer occurs in men without any significant family history of it.” TS 1:31 “Key biomarkers include PSA and prostate cancer gene 3, which is PCA3, and prostate-specific membrane antigen, or PSMA. Other biomarkers that are important for us to test include BRCA1, BRCA2, and Lynch syndrome–associated genes, which are MLH1, MSH2, MSH6, PMS2, and EPCAM. Biomarkers can be collected via your blood, urine, saliva, or tissue samples, so these are different ways that we can test and look for biomarkers in our patients.” TS 3:24 “It does matter how advanced the disease is. Usually, for our castrate-sensitive patients, they respond better to androgen deprivation therapy because that really is slowing down the growth of the cancer by reducing the available testosterone that the cancer needs to grow. Whereas our patients that are more advanced and have castrate-resistant prostate cancer, that cancer will continue to grow despite having the lowered testosterone levels, so they might need additional layers of treatment to really get their cancer under control.” TS 7:50 “When I talk to [patients] about biomarker testing, I tell them it's another tool in our toolbox that we can use to help us determine if they might benefit from other therapy options now or in the future. I tell them that sometimes we'll get a report back with a variant of unknown significance, and basically that means that we don't really know whether or not this has an impact on their health or risk factors for the disease. That can sometimes be a little bit of a concern for these patients, so we just have to reassure them that we're continually doing research around biomarker testing. The science is always advancing, so if there's something that [researchers] find in the future, we'll make them aware of that.” TS 9:08 “One of the biggest topics I think about is the inequity that exists in biomarker testing and research, especially surrounding the African American population. When these tests were developed, that population really wasn't studied as much, so there's not a lot of good data yet to make a decision or impact on those patients and that population.” TS: 12:30

Episode 199: Essential Screenings for Young AdultsDr. Lopez presents the most important screening tests for young adults. Dr. Arreaza adds some input on screening for depression and anxiety. Written by Alejandra Lopez, MD. Edits by Hector Arreaza, MD. Rio Bravo Family Medicine Residency Program. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Dr. Lopez: Screening is testing done to help identify disease in a person or population that typically appears healthy. Our goal as clinicians is to see which children are at increased risk of disease and will merit additional testing. For clinicians, testing should be both easy to perform and interpret. Now let's talk about prevention in young adults.Dr. Arreaza: I can see it is important to talk about young adults because that population may be very hesitant to go to the doctor, in general. Tell us more about it.Dr. Lopez: We all know that early detection and prevention are key, but many young adults skip routine check-ups. Why is that? Sometimes it's lack of awareness, fear, or just not knowing where to start. That's why today, we'll focus on four key screenings that every adolescent and young adult should know about.The Annual Physical ExamDr. Arreaza: I'm excited to talk about it. Many young adults only see a doctor when they're sick, but screenings help catch issues early, sometimes before symptoms even appear. Tell us about the annual wellness exams and why they matter.Dr. Lopez: Let's start with the basics—annual wellness exams. Many young people don't feel the need to see a doctor if they're feeling fine. So, these check-ups are important because many serious health conditions start silently, meaning no symptoms at first. Dr. Arreaza: What do we look for in an annual exam?Dr. Lopez: An annual check-up:· It is important to track growth and development (especially important for adolescents)It also helps monitor blood pressure, weight, and BMI to help find out who is at risk for elevated or low BP, underweight or overweight/obesity, by analyzing both weight and body mass index.· Discuss lifestyle habits like diet, exercise, and sleep· Evaluate whether you are up to date on vaccinations or due for age-appropriate vaccines.· Address any mental health concernsIt's also a great opportunity for young people to establish a relationship with a provider they trust. This makes it easier to discuss sensitive topics like sexual health or mental health.Dr. Arreaza: So, you say that the annual physical exam helps identify all these issues early, and at the same time, you establish a relationship of trust with a doctor who you may need at any time. STI ScreeningDr. Arreaza: That brings us to our second key screening: testing for sexually transmitted infections (STIs). There are many STIs. Let's focus on gonorrhea, chlamydia, syphilis, and HIV. Dr. Lopez, can you breakit  down for us? Who needs STI screening, and why is it so important?Dr. Lopez: Absolutely. The CDC recommends that ALL sexually active women under age 25 get screened for chlamydia and gonorrhea annually. HIV testing should also be done at least once for all young adults and annually for those at higher risk. Why is this the case? Because Many STIs have no symptoms, but untreated infections can lead to serious complications like infertility or pelvic inflammatory disease (PID) in women. The good news is that these infections are easily treatable if caught early. If caught later in life, then women and men alike are at risk for worse conditions. Dr. Arreaza: Let's talk about how do we do it?Dr. Lopez: STI screening is simple:· For chlamydia and gonorrhea, it's usually a urine test or a vaginal/cervical/oral swab.· For HIV, it's a quick blood test or even an oral swab.Many young adults avoid testing because of fear, stigma, or concerns about privacy, but most clinics offer confidential or even anonymous testing. Doctors do not share any information regarding the minor or young adult or any patient for that matter. AND if we are requested to share any information with others- then it is our obligation as doctors to ALWAYS ASK THE PATIENT before sharing ANY health information with third parties/other entitiesDr. Arreaza: And that includes parents of minors. Doctors are not allowed to discuss STI test results with parents of minors unless they are authorized by the patient or if the patient is in danger, for example, if this is a result of sexual abuse.Mental Health ScreeningsDr. Arreaza: Now, let's talk about something that's just as important as physical health—mental health. Depression and anxiety are very common in young people, but many don't seek help. How do doctors screen for depression?Dr. Lopez: Screening for depression is now a standard part of primary care. The most commonly used tool is the PHQ-9 questionnaire, which asks about:· Mood changes (sadness, hopelessness)· Loss of interest in activities· Sleep disturbances· Changes in appetite· Difficulty concentratingA score on this test can help determine whether someone is at risk of depression and needs further evaluation or support.Dr. Arreaza: And why should we screen for depression?Dr. Lopez: Because early treatment makes a huge difference. Depression can affect school, work, relationships, and even physical health. But with therapy, lifestyle changes, and sometimes medication, people can and do recover.I always tell young adults: Mental health is just as important as physical health. Seeking help is a sign of strength, not weakness.Dr. Arreaza: This is a USPSTF recommendation GRADE B. We are encouraged to screen adults, including pregnant and postpartum women, as well as older adults.HPV Screening & VaccinationDr. Lopez: Dr. Arreaza, finally, let's talk about HPV—one of the most preventable causes of cancer. The human papillomavirus (HPV) is the most common STI worldwide, and it's responsible for almost all cases of cervical cancer, as well as throat, anal, and penile cancers. The good news? The HPV vaccine is over 90% effective at preventing these cancers. Dr. Arreaza: In fact, from 2015 to 2018, U.S. women ages 14 to 19 experienced an 88% decrease in HPV-related disease. That's a direct result of the vaccine's effectiveness.Dr. Lopez: It's recommended for:· All boys and girls, starting at the age of 9. ACIP gave new recommendations for use of a 2-dose schedule for girls and boys who initiate the vaccination series at ages 9-14 years. Three doses remain recommended for persons who start HPV vaccination at ages 15-26 years and for immunocompromised persons.· Catch-up vaccination is recommended for people up to age 26 (and in some cases, up to 45 with provider recommendation)Dr. Arreaza: And what about screening for HPV? How do we screen?Dr. Lopez: Great question, Dr. Arreaza. Pap smears start at age 21, for all women regardless of sexual activity, and are repeated every 3-5 years depending on HPV testing. Many people think Pap smears check for STIs, but they actually look for abnormal cervical cells that could lead to cancer. HPV vaccination plus routine screening means cervical cancer is one of the most preventable cancers today!Closing Thoughts & Call to ActionDr. Arreaza: That wraps up today's discussion on essential health screenings for young adults! Dr. Lopez, any final take-home messages?Guest: My biggest message is don't wait until something is wrong to see a doctor. Preventative care is simple, quick, and can save lives.If you're between the ages of 13-26, here's what you should do:-Get an annual wellness exam-Get tested for STIs if sexually active-Check in on your mental health and talk to someone if you need support-Get the HPV vaccine if you haven't already and follow up on screeningTaking these small steps today leads to better health for years to come!Host: That's fantastic! Dr. Lopez. I hope all our primary care providers can take these easy steps to keep our young community healthy. If you found this episode helpful, share it with a friend, and don't forget to subscribe to our podcast for more practical health discussions.Dr. Lopez: Until next time—thanks for chiming in, medical community. Take care and take charge of your health!Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources. U.S. Centers for Disease Control and Prevention, CDC.gov, https://www.cdc.gov/std/treatment-guidelines/screening-recommendations.htm, accessed on June 26, 2025.Recommendation: Anxiety Disorders in Adults: Screening, United States Preventive Services Taskforce, June 20, 2023, https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/anxiety-adults-screening, accessed on June 26, 2025.Recommendation: Depression and Suicide Risk in Adults: Screening, United States Preventive Services Taskforce, June 20, 2023, https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults, accessed on June 26, 2025.Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

Lung cancer is Australia's fifth most diagnosed cancer, but causes the greatest number of deaths because it is often diagnosed too late. A new screening program has become available from July 1 that hopes to detect cases much earlier for those at the highest risk - which includes Indigenous Australians and some migrant communities. - 肺がんは、オーストラリアで5番目に多く診断されているがんですが、発見が遅れることが多く、がんによる死亡原因の中で最も多くなっています。こうした中、7月1日から新たな肺がんの検診プログラムが始まりました。

Discover how you can join the course today!:https://sevenfigurecrm.com/how-to-find-and-purchase-books-of-businessesOn this episode of the Seven Figures or Bust podcast, we dive into Apple's new iOS call screening update and what it means for insurance agents. We break down how it could impact your outreach, lead contact, and appointment setting. Don't get caught off guard—learn how to adapt before AEP hits!Learn more about getting your own VA with Hire Heroes here: https://app.hireheroes.com/signup?fpr=christian43Join our free private Facebook group for insurance agents: https://www.facebook.com/groups/551409828919739/Welcome to the Christian Brindle channel brought to you by Christian Brindle & Christian Brindle Insurance Services. This channel is here for the sole purpose of bringing training, tips, success stories, and personal development from Christian Brindle. Christian is a published author, hosts the ever popular Everything Medicare Podcast, and made six figures in the Medicare business by the time he was 25 years old.

Video games and movies seem like a perfect fit. For whatever reasons, adaptations done in either direction do not seem to work so well. Over the past few years, there have been a number of familiar horror franchises turned into games. They have been multiplayer affairs with limited shelf life. What makes the Hellraiser video game different?We really enjoyed In a Violent Nature. It was unique, had some great kills, and had an excellent big bad. It left itself open for a sequel, but is that a good thing? Can a movie shot in this style sustain a franchise or should it be left alone? We talk about the next installment and talk about our reservations.Shaw Studios is responsible for some of the most influential and well-regarded kung-fu movies of all time. Even those who have never seen any of their films are likely familiar with names like Five Deadly Venoms and The 36th Chamber of Shaolin. The Battle Wizard definitely belongs on that list.Awesome martial arts fights. A villain with extending metal legs that can break rock. Limb cutting lasers. A protagonist that eats exotic animals. The Battle Wizard has it all and then some. And in between all the wackiness it has a surprisingly well written will they/won't they love story that will gross you out until it warms your heart.Terrestrial has a lot going for it. Its director helmed Hot Tub Time Machine and co-wrote Grosse Pointe Blank and High Fidelity. The cast includes Jermaine Fowler and Pauline Chalamet. The premise is a fan favorite that has been used in screwball comedies and sitcoms. So, what happened?The writing is surprisingly dodgy. There is a science fiction aspect that does nothing to the story but seems like it is supposed to be something very important. Even worse, the characters are very poorly done. Most tellingly, Terrestrial goes out of its way to turn the main character into an awful person that is impossible to get behind. Which makes the movie impossible to enjoy. Adventures in Movies! is a part of the Morbidly Beautiful Podcast Network. Morbidly Beautiful is your one stop shop for all your horror needs. From the latest news and reviews to interviews and old favorites, it can be found at Morbidly Beautiful.Adventures in Movies! is hosted by Nathaniel and Blake. You can find Nathaniel on Instagram at nathaninpoortaste. Blake can be found on Twitter @foureyedhorror and on Instagram at foureyedhorror. You can reach us personally or on Twitter @AdventuresinMo1.Music in the background from https://www.FesliyanStudios.com

Can you prevent cervical cancer? How do you prevent cervical cancer? Can I check for cervical cancer at home? Who should get screened for cervical cancer? Does the HPV vaccine work? Our guest is Ritu Nayar, MD, professor of pathology and medical education and executive vice chair of pathology at Northwestern University Feinberg School of Medicine. In this episode, Dr. Nayar talks about where cervical cancer rates are on the rise and how new screening tools can help reverse that trend. American Medical Association CXO Todd Unger hosts.

Writer-director Domini Marshall is a talent on the rise. With short films like Go with Grace, Slap, and now her finest work yet, Howl, under her belt, Marshall is a force to be reckoned with. Her work is deeply personal, written from a perspective that invites audiences to engage with the internal mindset of her characters, and through that process, we're able to see the world differently.Guiding Domini's creative output is producer Josie Baynes, a equally impressive talent on the rise. Alongside Domini, Josie has worked with emerging talents like Annelise Hickey on her films Stranger, Brother. and Hafekasi, while also allowing cinematographer Matthew Chuang to build a body of work that is also reshaping how Australian stories are seen on screen.I highly recommend you seek out Domini's work on her website, DominiMarshall.com, where you can also seek out her web series her words, released during 2017-2019. It's a deeply informative series, one that pairs well with books like Taboo by Hannah Ferguson.In the following conversation, Domini and Josie talk through their creative process, how they manage to bring us into the internal mindset of their characters, and a lot more.Howl is screening at the Melbourne International Film Festival as part of the Aussie shorts package, alongside Stranger, Brother., I'm the Most Racist Person I Know, Mango Seed, and more. Screenings are held on 11 and 22 August, with online screenings taking place from 24 August. Visit MIFF.com.au for more details. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Miller Johnson employment attorneys Rebecca Strauss and Sarah Willey break down a new class action lawsuit against Workday over its use of AI in hiring. Could algorithm-driven screening expose employers to discrimination claims?

Drs. Patel and Armstrong discuss the implementation and evaluation of AI-powered diabetic retinopathy and diabetes-related macular edema screening and telemedicine, including ways to handle an influx of referrals, questions about reimbursement, staffing, and liability.

By Adam Turteltaub What you don't know can hurt you. And what you do know can hurt you.  Such is the dilemma of background screening. Companies want to know who they are hiring, but, explains Al Firato, CEO & Founder of HireSafe, some information is off limits. The 1964 Civil Rights Act and Title VII prohibit examinations of race, religion, ethnicity and more. In addition, federal and state regulations set limits on what background check firms can look at. That's not always a bad thing, Al points out. A conviction for a criminal offense from decades earlier should not be cause for immediate disqualification, especially if the person has since made amends. In addition, the conviction may not be relevant for the job at hand: a DUI for a prospective delivery driver is a lot different than one for someone who will be working at a desk all day. The EEOC has also made it clear that people are, in most cases, entitled to a second chance. With that said, background checks can be very useful for revealing exaggerated academic and work histories. Many prospective employees take advantage of the fact that, with so many mergers, it may be difficult, if not impossible, to verify previous employment. Listen in to learn more about the do's and don'ts of background screening. Listen now The Compliance Perspectives Podcast is sponsored by Athennian, a leading provider of entity management and governance software. Get started at www.athennian.com.

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide a comprehensive look at the growing challenge of EOCRC. Hosts: - Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center - Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian - Dr. Phil Bauer, Graduating Colorectal Surgical Oncology Fellow at Memorial Sloan Kettering Cancer Center  - Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer Center - Dr. Andrea Cercek - Gastrointestinal Medical Oncologist at Memorial Sloan Kettering Cancer Center - Dr. Y. Nancy You, MD MHSc - Professor, Department of Colon and Rectal Surgery at MD Anderson Cancer Center Learning objectives:  - Describe trends in incidence of colorectal cancer, with emphasis on the rise of EOCRC. - Identify age groups and demographics most affected by EOCRC. - Summarize USPSTF recommendations for colorectal cancer screening. - Distinguish between screening methods (e.g., colonoscopy, FIT-DNA) and their sensitivity. - Understand treatment approaches for colon and rectal cancer (CRC) - Understand the role of mismatch repair (MMR) status in guiding treatment. - Outline the importance of genetic counseling and testing in young patients. - Discuss racial, ethnic, and socioeconomic disparities in CRC incidence and outcomes. - Describe the impact of cancer treatment on fertility and sexual health. -  Review fertility preservation options. - Identify the value of integrated care teams for young CRC patients. References: 1.         Siegel, R. L. et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013. JNCI J. Natl. Cancer Inst. 109, djw322 (2017). https://pubmed.ncbi.nlm.nih.gov/28376186/ 2.         Abboud, Y. et al. Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis. Cancers 17, 1500 (2025). https://pubmed.ncbi.nlm.nih.gov/40361427/ 3.         Phang, R. et al. Is the Incidence of Early-Onset Adenocarcinomas in Aotearoa New Zealand Increasing? Asia Pac. J. Clin. Oncol.https://pubmed.ncbi.nlm.nih.gov/40384533/ 4.         Vitaloni, M. et al. Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries. BMC Gastroenterol. 25, 378 (2025). https://pubmed.ncbi.nlm.nih.gov/40375142/ 5.         Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. (2019) doi:10.1136/gutjnl-2019-319511. https://pubmed.ncbi.nlm.nih.gov/31488504/ 6.         Cercek, A. et al. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. J. Natl. Cancer Inst. 113, 1683–1692 (2021). https://pubmed.ncbi.nlm.nih.gov/34405229/ 7.         Zheng, X. et al. Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer. JNCI J. Natl. Cancer Inst. 113, 543–552 (2021). https://pubmed.ncbi.nlm.nih.gov/33136160/ 8.         Standl, E. & Schnell, O. Increased Risk of Cancer—An Integral Component of the Cardio–Renal–Metabolic Disease Cluster and Its Management. Cells 14, 564 (2025). https://pubmed.ncbi.nlm.nih.gov/40277890/ 9.         Muller, C., Ihionkhan, E., Stoffel, E. M. & Kupfer, S. S. Disparities in Early-Onset Colorectal Cancer. Cells 10, 1018 (2021). https://pubmed.ncbi.nlm.nih.gov/33925893/ 10.       US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 325, 1965–1977 (2021). https://pubmed.ncbi.nlm.nih.gov/34003218/ 11.       Fwelo, P. et al. Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors. Cancer Med. 14, e70612 (2025). https://pubmed.ncbi.nlm.nih.gov/40040375/ 12.       Lansdorp-Vogelaar, I. et al. Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates. Cancer Epidemiol. Biomarkers Prev. 21, 728–736 (2012). https://pubmed.ncbi.nlm.nih.gov/22514249/ 13.       Ko, T. M. et al. Low neighborhood socioeconomic status is associated with poor outcomes in young adults with colorectal cancer. Surgery 176, 626–632 (2024). https://pubmed.ncbi.nlm.nih.gov/38972769/ 14.       Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA. Cancer J. Clin. 73, 233–254 (2023). https://pubmed.ncbi.nlm.nih.gov/36856579/ 15.       Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A. & May, F. P. Optimal Strategies for Colorectal Cancer Screening. Curr. Treat. Options Oncol. 23, 474–493 (2022). https://pubmed.ncbi.nlm.nih.gov/35316477/ 16.       Zauber, A. G. The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference? Dig. Dis. Sci. 60, 681–691 (2015). https://pubmed.ncbi.nlm.nih.gov/25740556/ 17.       Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544–573 (2010). https://pubmed.ncbi.nlm.nih.gov/19998273/ 18.       Cercek, A. et al. Nonoperative Management of Mismatch Repair–Deficient Tumors. New England Journal of Medicine 392, 2297–2308 (2025). https://pubmed.ncbi.nlm.nih.gov/40293177/ 19.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations. Cancers 17, 1325 (2025). https://pubmed.ncbi.nlm.nih.gov/40282501/ 20.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer. Cancers 17, 1093 (2025). https://pubmed.ncbi.nlm.nih.gov/40227607/ 21.       Benson, A. B. et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. JNCCN 19, 329–359 (2021). https://pubmed.ncbi.nlm.nih.gov/33724754/ 22.       Christenson, E. S. et al. Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/40388545/ 23.       Dasari, A. et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. The Lancet 402, 41–53 (2023). https://pubmed.ncbi.nlm.nih.gov/37331369/ 24.       Strickler, J. H. et al. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Lancet Oncol. 24, 496–508 (2023). https://pubmed.ncbi.nlm.nih.gov/37142372/ 25.       Sauer, R. et al. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N. Engl. J. Med. 351, 1731–1740 (2004). https://pubmed.ncbi.nlm.nih.gov/15496622/ 26.       Cercek, A. et al. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol. 4, e180071 (2018). https://pubmed.ncbi.nlm.nih.gov/29566109/ 27.       Garcia-Aguilar, J. et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J. Clin. Oncol. 40, 2546–2556 (2022). https://pubmed.ncbi.nlm.nih.gov/35483010/ 28.       Schrag, D. et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N. Engl. J. Med. 389, 322–334 (2023). https://pubmed.ncbi.nlm.nih.gov/37272534/ 29.       Kunkler, I. H., Williams, L. J., Jack, W. J. L., Cameron, D. A. & Dixon, J. M. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N. Engl. J. Med. 388, 585–594 (2023). https://pubmed.ncbi.nlm.nih.gov/36791159/ 30.       Jacobsen, R. L., Macpherson, C. F., Pflugeisen, B. M. & Johnson, R. H. Care Experience, by Site of Care, for Adolescents and Young Adults With Cancer. JCO Oncol. Pract. (2021) doi:10.1200/OP.20.00840. https://pubmed.ncbi.nlm.nih.gov/33566700/ 31.       Ruddy, K. J. et al. Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer. J. Clin. Oncol. (2014) doi:10.1200/JCO.2013.52.8877. https://pubmed.ncbi.nlm.nih.gov/24567428/ 32.       Su, H. I. et al. Fertility Preservation in People With Cancer: ASCO Guideline Update. J. Clin. Oncol. 43, 1488–1515 (2025). https://pubmed.ncbi.nlm.nih.gov/40106739/ 33.       Smith, K. L., Gracia, C., Sokalska, A. & Moore, H. Advances in Fertility Preservation for Young Women With Cancer. Am. Soc. Clin. Oncol. Educ. Book 27–37 (2018) doi:10.1200/EDBK_208301. https://pubmed.ncbi.nlm.nih.gov/30231357/ 34.       Blumenfeld, Z. How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries. The Oncologist 12, 1044–1054 (2007). 35.       Bhagavath, B. The current and future state of surgery in reproductive endocrinology. Curr. Opin. Obstet. Gynecol. 34, 164 (2022). 36.       Ribeiro, R. et al. Uterine transposition: technique and a case report. Fertil. Steril. 108, 320-324.e1 (2017). 37.       Yazdani, A., Sweterlitsch, K. M., Kim, H., Flyckt, R. L. & Christianson, M. S. Surgical Innovations to Protect Fertility from Oncologic Pelvic Radiation Therapy: Ovarian Transposition and Uterine Fixation. J. Clin. Med. 13, 5577 (2024). 38.       Holowatyj, A. N., Eng, C. & Lewis, M. A. Incorporating Reproductive Health in the Clinical Management of Early-Onset Colorectal Cancer. JCO Oncol. Pract. 18, 169–172 (2022). ***Behind the Knife Colorectal Surgery Oral Board Audio Review: https://app.behindtheknife.org/course-details/colorectal-surgery-oral-board-audio-review Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-442 Overview: Listen in as we review the USPSTF's recently proposed recommendations for screening women who are at risk for developing osteoporosis. Gain confidence to navigate these changes and engage patients in shared decision-making to ensure timely, evidence-based preventive care. Episode resource links: JAMA. 2025;333(6):498–508. doi:10.1001/jama.2024.27154 Guest: Robert A. Baldor MD, FAAFP   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com